Zomedica Corp [AMEX: ZOM] loss -1.54% or 0.0 points to close at $0.12 with a heavy trading volume of 4770960 shares.
The daily chart for ZOM points out that the company has recorded -14.71% loss over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 3.35M shares, ZOM reached to a volume of 4770960 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Zomedica Corp [ZOM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZOM shares is $0.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZOM stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Dawson James have made an estimate for Zomedica Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 06, 2023.
The Average True Range (ATR) for Zomedica Corp is set at 0.00, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 4.55. The Price to Book ratio for the last quarter was 0.57, with the Price to Cash per share for the same quarter was set at 0.08.
Trading performance analysis for ZOM stock
Zomedica Corp [ZOM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.70. With this latest performance, ZOM shares dropped by -11.66% in over the last four-week period, additionally sinking by -14.71% over the last 6 months – not to mention a drop of -21.86% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 41.10, with the RSI for the last a single of trading hit 39.78, and the three-weeks RSI is set at 42.03 for Zomedica Corp [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.1288, while it was recorded at 0.1210 for the last single week of trading, and 0.1403 for the last 200 days.
Zomedica Corp [ZOM]: A deeper dive into fundamental analysis
Zomedica Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.68 and a Current Ratio set at 11.39.
Zomedica Corp [ZOM]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Zomedica Corp posted -0.01/share EPS, while the average EPS was predicted by analysts to be reported at 0/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZOM.
An analysis of Institutional ownership at Zomedica Corp [ZOM]
There are presently around $8.63%, or 8.79%% of ZOM stock, in the hands of institutional investors. The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 29.93 million shares, which is approximately 3.054%. BLACKROCK INC., holding 26.21 million shares of the stock with an approximate value of $$334.65 million in ZOM stocks shares; and BLACKROCK INC., currently with $$330.43 million in ZOM stock with ownership which is approximately 2.6405%.
